The pharmaceutical sector is one of the most dynamic industries in the UK and is a major contributor to the country’s economy. The pharmaceutical market in the UK is set to grow from $28.8 billion in 2015 to approximately $43 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 8.4%, driven primarily by a robust life sciences industry. The pharmaceutical industry was the sixth largest contributor to the UK’s balance of trade, contributing $46.9 billion (£32.4 billion) to the economy in 2014, according to the Association of the British Pharmaceutical Industry.
GlobalData’s CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK report provides analysis of the pharmaceutical market landscape in the UK, and the impact of the current and emerging market access strategies used by the pharmaceutical industry for new and existing drugs. It discusses the regulatory requirements, key health insurance trends, government healthcare policies, and general industry trends.
Single User Price: $1,995